Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 15, 2020

SELL
$2.28 - $6.6 $24,851 - $71,940
-10,900 Reduced 6.81%
149,100 $552,000
Q3 2019

Nov 13, 2019

SELL
$2.23 - $4.61 $206,498 - $426,886
-92,600 Reduced 36.66%
160,000 $514,000
Q3 2018

Nov 14, 2018

SELL
$9.77 - $17.15 $8.07 Million - $14.2 Million
-825,900 Reduced 76.58%
252,600 $4.25 Million
Q2 2018

Aug 14, 2018

BUY
$5.43 - $9.83 $5.86 Million - $10.6 Million
1,078,500 New
1,078,500 $10.2 Million

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.